2005
DOI: 10.1111/j.1600-051x.2005.00755.x
|View full text |Cite
|
Sign up to set email alerts
|

In vitro studies of a degradable device for controlled‐release of meloxicam

Abstract: As a conclusion, cross-linked gelatin matrix films may be considered as a suitable inert material for obtaining a prolonged local release of meloxicam as an adjunct to the mechanical periodontal treatment. As required, further in vitro and in vivo studies will be performed before starting clinical applications of this controlled-release formulation of the anti-inflammatory agent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 19 publications
0
19
0
Order By: Relevance
“…According to their relative inhibition of COX isoenzymes, NSAIDs can be classified as non-selective, COX-2 preferential or COX-2 selective 10,26 . Meloxicam is a NSAID of the acidic enolic class that preferentially inhibits the inducible COX-2 and shows a weaker influence on constitutive COX-1 10,16,17 ; it is thus largely used for treatment of acute and chronic painful, inflammatory and degenerative disorders 16,25,32 .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…According to their relative inhibition of COX isoenzymes, NSAIDs can be classified as non-selective, COX-2 preferential or COX-2 selective 10,26 . Meloxicam is a NSAID of the acidic enolic class that preferentially inhibits the inducible COX-2 and shows a weaker influence on constitutive COX-1 10,16,17 ; it is thus largely used for treatment of acute and chronic painful, inflammatory and degenerative disorders 16,25,32 .…”
mentioning
confidence: 99%
“…Meloxicam is a NSAID of the acidic enolic class that preferentially inhibits the inducible COX-2 and shows a weaker influence on constitutive COX-1 10,16,17 ; it is thus largely used for treatment of acute and chronic painful, inflammatory and degenerative disorders 16,25,32 . In dentistry, there are few studies concerning the use of meloxicam 1,4,6,9,10,25 , and none of them assessed pain control in dental surgeries with postoperative administration of this agent.…”
mentioning
confidence: 99%
“…This difference in release rate is due to the decrease in the permeability coefficient of the cross-linked membrane resulting from the cross-link points (23). A similar decrease in meloxicam release from cross-linked gelatin inserts has been reported recently (24). Table II shows the treatment of release data according to the Higuchi equation.…”
Section: Methodsmentioning
confidence: 91%
“…Gelatins from porcine skin (type A) were purchased from Sigma Co. Gelatin materials were prepared in the form of the films with thickness of about 0.1 mm; such thin films were used, for example, in dentistry as a biodegradable device for controlled release of antioxidant meloxicam into periodontal pocket [10]. To produce the films, 2 mL of film-forming gelatin solution (FFGS) was poured on a polymer substrate as a thin layer and dried at room temperature for several days.…”
Section: Experimental Preparation Of Gelatin Filmsmentioning
confidence: 99%